Tetragon Partners GP Ltd Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001515070

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedTechnology TiltHigh Turnover how tags are computed

Q1 2026 · 34 positions · Total reported value $508.90M · Top-10 concentration 83.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 37.5% · 4 new · 5 cut · 6 exited

Active Share (vs S&P 500): 99.7% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +7.8% · vs SPY +5.7% · Prev Value $613.69M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +5.0% · vs SPY +2.8% · Latest Value $730.98M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2026 13F filing, Tetragon Partners GP Ltd disclosed 34 equity positions with a combined reported value of $508.90M. The filing implies a focused portfolio: its ten largest positions account for 83.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Technology Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were PATH ($279.80M), KGEI ($37.52M), WBD ($25.37M). By sector, the heaviest allocations are Technology 60.8%, Health Care 23.6%. Versus the prior quarter, allocation shifted toward Communication Services (+5.0pp), Health Care (+2.4pp) and away from Other (-1.3pp), Consumer Discretionary (-1.5pp).

Versus the prior quarter, Tetragon Partners GP Ltd opened 4 new positions, trimmed 5 and fully exited 6, a turnover rate of 37.5% of positions. The portfolio's overlap with the prior quarter was 63% of names.

The largest new positions opened in Q1 2026 were WBD ($25.37M), DFTX ($3.78M), SLNO ($3.42M).

Of the 6 positions fully exited versus the prior quarter, the largest were RAPT ($4.46M), FOLD ($3.71M), ZVRA ($1.72M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • WBD WARNER BROS DISCOVERY INC · $25.37M
  • DFTX DEFINIUM THERAPEUTICS INC · $3.78M
  • SLNO SOLENO THERAPEUTICS INC · $3.42M
  • ACAD ACADIA PHARMACEUTICALS INC · $3.22M
  • IONS IONIS PHARMACEUTICALS INC · $3.14M
  • RLAY RELAY THERAPEUTICS INC · $1.81M
  • AARD AARDVARK THERAPEUTICS INC · $1.19M
  • TECX TECTONIC THERAPEUTIC INC · $1.16M

Fully Exited (vs previous quarter)

  • RAPT RAPT THERAPEUTICS INC · prev qtr: $4.46M
  • FOLD AMICUS THERAPEUTIC · prev qtr: $3.71M
  • ZVRA ZEVRA THERAPEUTICS INC · prev qtr: $1.72M
  • AVDL AVADEL PHARMACEUTICALS · prev qtr: $943.09K

Insider Transactions (Form 4)

Latest Tetragon Partners GP Ltd buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Tetragon Partners GP Ltd files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 36 positions worth $613.69M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 36 positions · $613.69M reported value (Q2 2026)
  • Top 10 holdings = 76.6% of reported value
  • Largest position: PATH (UIPATH INC CL A) at 54.8%
  • Average position size: $17.05M

Sector Tilt

  • Information Technology 60.8%
  • Health Care 30.2%
  • Energy 5.5%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 6 new, 16 added, 7 reduced, 4 exited
  • 7 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 60.8%
Health Care 23.6%
Energy 7.4%
Other 0.7%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 25.21M $279.80M 54.98%
54.98%
Add
2 6.83M $37.52M 7.37%
7.37%
Reduce
3 923.73K $25.37M 4.98%
4.98%
New
4 250.00K $14.91M 2.93%
2.93%
Add
5 1.00M $13.30M 2.61%
2.61%
Hold
6 2.20M $13.20M 2.59%
2.59%
Hold
7 9.50M $13.11M 2.58%
2.58%
Hold
8 312.32K $9.91M 1.95%
1.95%
Add
9 127.20K $7.98M 1.57%
1.57%
Add
10 103.04K $7.41M 1.46%
1.46%
Add
11 1.29M $7.16M 1.41%
1.41%
Reduce
12 221.61K $6.26M 1.23%
1.23%
Add
13 159.79K $5.65M 1.11%
1.11%
Add
14 164.84K $5.58M 1.10%
1.10%
Add
15 218.51K $5.43M 1.07%
1.07%
Add
16 15.95K $5.14M 1.01%
1.01%
Reduce
17 19.67K $5.08M 1.00%
1.00%
Add
18 258.13K $4.68M 0.92%
0.92%
Add
19 317.88K $4.42M 0.87%
0.87%
Add
20 145.48K $4.34M 0.85%
0.85%
Add
21 199.99K $3.78M 0.74%
0.74%
New
22 102.12K $3.42M 0.67%
0.67%
New
23 20.06K $3.39M 0.67%
0.67%
Reduce
24 119.34K $3.34M 0.66%
0.66%
Add
25 630.16K $3.32M 0.65%
0.65%
Add
26 144.62K $3.22M 0.63%
0.63%
New
27 41.76K $3.14M 0.62%
0.62%
New
28 112.11K $2.28M 0.45%
0.45%
Reduce
29 181.54K $1.81M 0.35%
0.35%
New
30 10.00K $1.51M 0.30%
0.30%
Hold
31 316.62K $1.19M 0.23%
0.23%
New
32 37.59K $1.16M 0.23%
0.23%
New
33 39.47K $826.96K 0.16%
0.16%
New
34 50.00K $278.50K 0.06%
0.06%
New

FAQ

What did Tetragon Partners GP Ltd buy in 2026-Q1?

In its 2026-Q1 13F filing, Tetragon Partners GP Ltd reported 34 equity positions worth $508.90M in aggregate; its largest disclosed positions were PATH ($279.80M), KGEI ($37.52M), WBD ($25.37M).

How large is Tetragon Partners GP Ltd's portfolio?

Tetragon Partners GP Ltd reported $508.90M of long equity holdings across 34 positions as of 2026-Q1. Top-10 holdings account for 83.0% of reported value.

What is Tetragon Partners GP Ltd's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tetragon-partners-gp/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →